Mycobacterium tuberculosis H37Rv : In Silico Drug Targets Identification by Metabolic Pathways Analysis

Abstract EN

Mycobacterium tuberculosis (Mtb) is a pathogenic bacteria species in the genus Mycobacterium and the causative agent of most cases of tuberculosis.

Tuberculosis (TB) is the leading cause of death in the world from a bacterial infectious disease.

This antibiotic resistance strain lead to development of the new antibiotics or drug molecules which can kill or suppress the growth of Mycobacterium tuberculosis.

We have performed an in silico comparative analysis of metabolic pathways of the host Homo sapiens and the pathogen Mycobacterium tuberculosis (H37Rv).

Novel efforts in developing drugs that target the intracellular metabolism of M.

tuberculosis often focus on metabolic pathways that are specific to M.

tuberculosis.

We have identified five unique pathways for Mycobacterium tuberculosis having a number of 60 enzymes, which are nonhomologous to Homo sapiens protein sequences, and among them there were 55 enzymes, which are nonhomologous to Homo sapiens protein sequences.

These enzymes were also found to be essential for survival of the Mycobacterium tuberculosis according to the DEG database.

Further, the functional analysis using Uniprot showed involvement of all the unique enzymes in the different cellular components.